Atlas Trials

Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

Clinical trial NCT00682760 · COMPLETED

Trial details

NCT number
NCT00682760
Sponsor
Pacific Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Blepharospasm
Start date
2005-10-01
Primary completion
2006-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.